Dr Neil Rodrigues
Reader
- rodriguesn@cardiff.ac.uk
- +44 (0)29 2068 8507
- European Cancer Stem Cell Research Institute, Cardiff School of Biosciences, Hadyn Ellis Building, Maindy Road, Cardiff, CF24 4HQ
Research overview
My laboratory is interested in haematopoietic stem/progenitor cell biology and their dysregulation in bone marrow failure and haematologic cancer. We are investigating the transcriptional and post-transcriptional mechanisms regulating haematopoietic stem/progenitor cells, myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML) with the ultimate purpose of identifying more specific and less toxic treatment strategies for MDS and AML.
Lab staff
- Dr Gui Jie Feng, Research Associate
- Dr Juan Menendez Gonzalez, Research Associate
- Dr. Marwa Abu-Serie, Visiting Research Associate
- Alhomidi Almotiri (PhD student)
- Amani Alsayari (PhD student)
- Ali Abdelfattah, PhD student
- Leigh-Anne Thomas, PhD student
- Badi Alotaibi, PhD student
- Hamed Ahmad A Alzahrani, PhD student
- Emma Wilde, MRes student
Current grant support
- Sêr Cymru National Research Network in Health and Life Sciences
- Leukaemia Cancer Society
- British Society for Haematology
- Cancer Research UK Cardiff Centre (Development Fund)
- Sêr Cymru Richard Whipp Studentships
- Royal Embassy of Saudi Arabia
Dr. Rodrigues has a longstanding interest in stem cell biology, with a particular interest in the haematopoietic system. He initially trained in Professor David Scadden's laboratory at Harvard Medical School and went on to obtain a D.Phil in Clinical Medicine from Green College, University of Oxford under the joint supervision of Professors Scadden, Paresh Vyas and Tariq Enver. Following several years of teaching at Oxford and post-doctoral research training in the Enver laboratory, he established his NIH funded laboratory at Boston University School of Medicine where he also held an Assistant Professor appointment. In September 2013, Dr. Rodrigues was recruited to re-establish his laboratory at the European Cancer Stem Cell Institute. He holds a Readership at Cardiff University.
2019
- Menendez Gonzalez, J. B.et al. 2019. Inhibition of GATA2 restrains cell proliferation and enhances apoptosis and chemotherapy mediated apoptosis in human GATA2 overexpressing AML cells. Scientific Reports 9, article number: 12212. (10.1038/s41598-019-48589-0)
- Menendez Gonzalez, J. B.et al. 2019. Gata2 as a crucial regulator of stem cells in adult hematopoiesis and acute myeloid leukemia. Stem Cell Reports 13(2), pp. 291-306. (10.1016/j.stemcr.2019.07.005)
- Menendez-Gonzalez, J. B.et al. 2019. Isolation of murine hematopoietic stem cells. In: Boyd, A. S. ed. Immunological Tolerance: Methods and Protocols., Vol. 1899. Methods in Molecular Biology New York: Humana Press, pp. 15-23., (10.1007/978-1-4939-8938-6_2)
2018
- Boyd, A. S. and Rodrigues, N. P. 2018. Stem cells cycle toward immune surveillance. Immunity 48(2), pp. 187-190. (10.1016/j.immuni.2018.02.006)
2017
- Portero Migueles, R.et al. 2017. Transcriptional regulation of Hhex in hematopoiesis and hematopoietic stem cell ontogeny. Developmental Biology 424(2), pp. 236-245. (10.1016/j.ydbio.2016.12.021)
- Guitart, A. V.et al. 2017. Fumarate hydratase is a critical regulator of hematopoietic stem cell functions. Journal of Experimental Medicine 214(3), pp. -., article number: 719. (10.1084/jem.20161087)
2013
- Rodrigues, N. and Tipping, A. J. 2013. Transcription factor GATA-2 regulates quiescence of hematopoietic stem and progenitor cells. In: Hayat, M. A. ed. Tumor Dormancy, Quiescence, and Senescence, Volume 2., Vol. 2. Springer, pp. 277-288., (10.1007/978-94-007-7726-2_26)
- Guha, P.et al. 2013. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell 12(4), pp. 407-412. (10.1016/j.stem.2013.01.006)
2012
- Boyd, A. S.et al. 2012. Concise review: Immune recognition of induced pluripotent stem cells. Stem Cells 30(5), pp. 797-803. (10.1002/stem.1066)
- Rodrigues, N.et al. 2012. GATA-2 mediated regulation of normal hematopoietic stem/progenitor cell function, myelodysplasia and myeloid leukemia. The International Journal of Biochemistry & Cell Biology 44(3), pp. 457-460. (10.1016/j.biocel.2011.12.004)
2009
- Kranc, K. R.et al. 2009. Cited2 is an essential regulator of adult hematopoietic stem cells. Cell Stem Cell 5(6), pp. 659-665. (10.1016/j.stem.2009.11.001)
- Tipping, A. J.et al. 2009. High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle. Blood 113(12), pp. 2661-2672. (10.1182/blood-2008-06-161117)
2008
- Rodrigues, N.et al. 2008. GATA-2 regulates granulocyte-macrophage progenitor cell function. Blood 112(13), pp. 4862-4873. (10.1182/blood-2008-01-136564)
2007
- Nijnik, A.et al. 2007. DNA repair is limiting for haematopoietic stem cells during ageing. Nature 447(7145), pp. 686-690. (10.1038/nature05875)
2005
- Rodrigues, N.et al. 2005. Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. Blood 106(2), pp. 477-484. (10.1182/blood-2004-08-2989)
- Craiu, A.et al. 2005. Flowing cells through pulsed electric fields efficiently purges stem cell preparations of contaminating myeloma cells while preserving stem cell function. Blood 105(5), pp. 2235-2238. (10.1182/blood-2003-12-4399)
2004
- Qiu, J.et al. 2004. Regenerative response in ischemic brain restricted by p21cip1/waf1. Journal of Experimental Medicine 199(7), pp. 937-945. (10.1084/jem.20031385)
2002
- Adams, G. B.et al. 2002. Heterologous cells cooperate to augment stem cell migration, homing, and engraftment. Blood 101(1), pp. 45-51. (10.1182/blood-2002-02-0486)
2001
- Cheng, T.et al. 2001. Transforming growth factor β1 mediates cell-cycle arrest of primitive hematopoietic cells independent of p21Cip1/Waf1or p27Kip1. Blood 98(13), pp. 3643-3649. (10.1182/blood.V98.13.3643)
2000
- Cheng, T.et al. 2000. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287(5459), pp. 1804-1808. (10.1126/science.287.5459.1804)
- Cheng, T.et al. 2000. Stem cell repopulation efficiency but not pool size is governed by p27 (kip1). Nature Medicine 6, pp. 1235-1240. (10.1038/81335)